1 Study Coverage
    1.1 Oligonucleotide API Product Introduction
    1.2 Market by Type
        1.2.1 Global Oligonucleotide API Market Size by Type, 2017 VS 2021 VS 2028
        1.2.2 Antisense Oligonucleotides API
        1.2.3 Small Interfering RNA (siRNA) API
        1.2.4 MiRNA API
        1.2.5 CpG Oligonucleotides API
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Oligonucleotide API Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Contract Manufacturing Organizations (CMOs)
        1.3.3 Pharmaceutical Companies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Oligonucleotide API Production
    2.1 Global Oligonucleotide API Production Capacity (2017-2028)
    2.2 Global Oligonucleotide API Production by Region: 2017 VS 2021 VS 2028
    2.3 Global Oligonucleotide API Production by Region
        2.3.1 Global Oligonucleotide API Historic Production by Region (2017-2022)
        2.3.2 Global Oligonucleotide API Forecasted Production by Region (2023-2028)
    2.4 North America
    2.5 Europe
    2.6 China
    2.7 Japan
3 Global Oligonucleotide API Sales in Volume & Value Estimates and Forecasts
    3.1 Global Oligonucleotide API Sales Estimates and Forecasts 2017-2028
    3.2 Global Oligonucleotide API Revenue Estimates and Forecasts 2017-2028
    3.3 Global Oligonucleotide API Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global Oligonucleotide API Sales by Region
        3.4.1 Global Oligonucleotide API Sales by Region (2017-2022)
        3.4.2 Global Sales Oligonucleotide API by Region (2023-2028)
    3.5 Global Oligonucleotide API Revenue by Region
        3.5.1 Global Oligonucleotide API Revenue by Region (2017-2022)
        3.5.2 Global Oligonucleotide API Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global Oligonucleotide API Production Capacity by Manufacturers
    4.2 Global Oligonucleotide API Sales by Manufacturers
        4.2.1 Global Oligonucleotide API Sales by Manufacturers (2017-2022)
        4.2.2 Global Oligonucleotide API Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Oligonucleotide API in 2021
    4.3 Global Oligonucleotide API Revenue by Manufacturers
        4.3.1 Global Oligonucleotide API Revenue by Manufacturers (2017-2022)
        4.3.2 Global Oligonucleotide API Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by Oligonucleotide API Revenue in 2021
    4.4 Global Oligonucleotide API Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global Oligonucleotide API Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
    5.1 Global Oligonucleotide API Sales by Type
        5.1.1 Global Oligonucleotide API Historical Sales by Type (2017-2022)
        5.1.2 Global Oligonucleotide API Forecasted Sales by Type (2023-2028)
        5.1.3 Global Oligonucleotide API Sales Market Share by Type (2017-2028)
    5.2 Global Oligonucleotide API Revenue by Type
        5.2.1 Global Oligonucleotide API Historical Revenue by Type (2017-2022)
        5.2.2 Global Oligonucleotide API Forecasted Revenue by Type (2023-2028)
        5.2.3 Global Oligonucleotide API Revenue Market Share by Type (2017-2028)
    5.3 Global Oligonucleotide API Price by Type
        5.3.1 Global Oligonucleotide API Price by Type (2017-2022)
        5.3.2 Global Oligonucleotide API Price Forecast by Type (2023-2028)
6 Market Size by Application
    6.1 Global Oligonucleotide API Sales by Application
        6.1.1 Global Oligonucleotide API Historical Sales by Application (2017-2022)
        6.1.2 Global Oligonucleotide API Forecasted Sales by Application (2023-2028)
        6.1.3 Global Oligonucleotide API Sales Market Share by Application (2017-2028)
    6.2 Global Oligonucleotide API Revenue by Application
        6.2.1 Global Oligonucleotide API Historical Revenue by Application (2017-2022)
        6.2.2 Global Oligonucleotide API Forecasted Revenue by Application (2023-2028)
        6.2.3 Global Oligonucleotide API Revenue Market Share by Application (2017-2028)
    6.3 Global Oligonucleotide API Price by Application
        6.3.1 Global Oligonucleotide API Price by Application (2017-2022)
        6.3.2 Global Oligonucleotide API Price Forecast by Application (2023-2028)
7 North America
    7.1 North America Oligonucleotide API Market Size by Type
        7.1.1 North America Oligonucleotide API Sales by Type (2017-2028)
        7.1.2 North America Oligonucleotide API Revenue by Type (2017-2028)
    7.2 North America Oligonucleotide API Market Size by Application
        7.2.1 North America Oligonucleotide API Sales by Application (2017-2028)
        7.2.2 North America Oligonucleotide API Revenue by Application (2017-2028)
    7.3 North America Oligonucleotide API Sales by Country
        7.3.1 North America Oligonucleotide API Sales by Country (2017-2028)
        7.3.2 North America Oligonucleotide API Revenue by Country (2017-2028)
        7.3.3 U.S.
        7.3.4 Canada
8 Europe
    8.1 Europe Oligonucleotide API Market Size by Type
        8.1.1 Europe Oligonucleotide API Sales by Type (2017-2028)
        8.1.2 Europe Oligonucleotide API Revenue by Type (2017-2028)
    8.2 Europe Oligonucleotide API Market Size by Application
        8.2.1 Europe Oligonucleotide API Sales by Application (2017-2028)
        8.2.2 Europe Oligonucleotide API Revenue by Application (2017-2028)
    8.3 Europe Oligonucleotide API Sales by Country
        8.3.1 Europe Oligonucleotide API Sales by Country (2017-2028)
        8.3.2 Europe Oligonucleotide API Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific Oligonucleotide API Market Size by Type
        9.1.1 Asia Pacific Oligonucleotide API Sales by Type (2017-2028)
        9.1.2 Asia Pacific Oligonucleotide API Revenue by Type (2017-2028)
    9.2 Asia Pacific Oligonucleotide API Market Size by Application
        9.2.1 Asia Pacific Oligonucleotide API Sales by Application (2017-2028)
        9.2.2 Asia Pacific Oligonucleotide API Revenue by Application (2017-2028)
    9.3 Asia Pacific Oligonucleotide API Sales by Region
        9.3.1 Asia Pacific Oligonucleotide API Sales by Region (2017-2028)
        9.3.2 Asia Pacific Oligonucleotide API Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
        9.3.12 Philippines
10 Latin America
    10.1 Latin America Oligonucleotide API Market Size by Type
        10.1.1 Latin America Oligonucleotide API Sales by Type (2017-2028)
        10.1.2 Latin America Oligonucleotide API Revenue by Type (2017-2028)
    10.2 Latin America Oligonucleotide API Market Size by Application
        10.2.1 Latin America Oligonucleotide API Sales by Application (2017-2028)
        10.2.2 Latin America Oligonucleotide API Revenue by Application (2017-2028)
    10.3 Latin America Oligonucleotide API Sales by Country
        10.3.1 Latin America Oligonucleotide API Sales by Country (2017-2028)
        10.3.2 Latin America Oligonucleotide API Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
11 Middle East and Africa
    11.1 Middle East and Africa Oligonucleotide API Market Size by Type
        11.1.1 Middle East and Africa Oligonucleotide API Sales by Type (2017-2028)
        11.1.2 Middle East and Africa Oligonucleotide API Revenue by Type (2017-2028)
    11.2 Middle East and Africa Oligonucleotide API Market Size by Application
        11.2.1 Middle East and Africa Oligonucleotide API Sales by Application (2017-2028)
        11.2.2 Middle East and Africa Oligonucleotide API Revenue by Application (2017-2028)
    11.3 Middle East and Africa Oligonucleotide API Sales by Country
        11.3.1 Middle East and Africa Oligonucleotide API Sales by Country (2017-2028)
        11.3.2 Middle East and Africa Oligonucleotide API Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 UAE
12 Corporate Profiles
    12.1 Jazz Pharmaceuticals
        12.1.1 Jazz Pharmaceuticals Corporation Information
        12.1.2 Jazz Pharmaceuticals Overview
        12.1.3 Jazz Pharmaceuticals Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 Jazz Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 Jazz Pharmaceuticals Recent Developments
    12.2 Sarepta Therapeutics
        12.2.1 Sarepta Therapeutics Corporation Information
        12.2.2 Sarepta Therapeutics Overview
        12.2.3 Sarepta Therapeutics Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Sarepta Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Sarepta Therapeutics Recent Developments
    12.3 Biogen
        12.3.1 Biogen Corporation Information
        12.3.2 Biogen Overview
        12.3.3 Biogen Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Biogen Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Biogen Recent Developments
    12.4 Dynavax Technologies
        12.4.1 Dynavax Technologies Corporation Information
        12.4.2 Dynavax Technologies Overview
        12.4.3 Dynavax Technologies Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Dynavax Technologies Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Dynavax Technologies Recent Developments
    12.5 Akcea Therapeutics
        12.5.1 Akcea Therapeutics Corporation Information
        12.5.2 Akcea Therapeutics Overview
        12.5.3 Akcea Therapeutics Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Akcea Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Akcea Therapeutics Recent Developments
    12.6 Alnylam Pharmaceuticals
        12.6.1 Alnylam Pharmaceuticals Corporation Information
        12.6.2 Alnylam Pharmaceuticals Overview
        12.6.3 Alnylam Pharmaceuticals Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 Alnylam Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 Alnylam Pharmaceuticals Recent Developments
    12.7 Nitto Denko (Avecia)
        12.7.1 Nitto Denko (Avecia) Corporation Information
        12.7.2 Nitto Denko (Avecia) Overview
        12.7.3 Nitto Denko (Avecia) Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Nitto Denko (Avecia) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Nitto Denko (Avecia) Recent Developments
    12.8 Ajinomoto (GeneDesign)
        12.8.1 Ajinomoto (GeneDesign) Corporation Information
        12.8.2 Ajinomoto (GeneDesign) Overview
        12.8.3 Ajinomoto (GeneDesign) Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 Ajinomoto (GeneDesign) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 Ajinomoto (GeneDesign) Recent Developments
    12.9 RiboBio
        12.9.1 RiboBio Corporation Information
        12.9.2 RiboBio Overview
        12.9.3 RiboBio Oligonucleotide API Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 RiboBio Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 RiboBio Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 Oligonucleotide API Industry Chain Analysis
    13.2 Oligonucleotide API Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 Oligonucleotide API Production Mode & Process
    13.4 Oligonucleotide API Sales and Marketing
        13.4.1 Oligonucleotide API Sales Channels
        13.4.2 Oligonucleotide API Distributors
    13.5 Oligonucleotide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 Oligonucleotide API Industry Trends
    14.2 Oligonucleotide API Market Drivers
    14.3 Oligonucleotide API Market Challenges
    14.4 Oligonucleotide API Market Restraints
15 Key Finding in The Global Oligonucleotide API Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Oligonucleotide API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Antisense Oligonucleotides API
    Table 3. Major Manufacturers of Small Interfering RNA (siRNA) API
    Table 4. Major Manufacturers of MiRNA API
    Table 5. Major Manufacturers of CpG Oligonucleotides API
    Table 6. Major Manufacturers of Others
    Table 7. Global Oligonucleotide API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 8. Global Oligonucleotide API Production by Region: 2017 VS 2021 VS 2028 (Ton)
    Table 9. Global Oligonucleotide API Production by Region (2017-2022) & (Ton)
    Table 10. Global Oligonucleotide API Production Market Share by Region (2017-2022)
    Table 11. Global Oligonucleotide API Production by Region (2023-2028) & (Ton)
    Table 12. Global Oligonucleotide API Production Market Share by Region (2023-2028)
    Table 13. Global Oligonucleotide API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 14. Global Oligonucleotide API Sales by Region (2017-2022) & (Ton)
    Table 15. Global Oligonucleotide API Sales Market Share by Region (2017-2022)
    Table 16. Global Oligonucleotide API Sales by Region (2023-2028) & (Ton)
    Table 17. Global Oligonucleotide API Sales Market Share by Region (2023-2028)
    Table 18. Global Oligonucleotide API Revenue by Region (2017-2022) & (US$ Million)
    Table 19. Global Oligonucleotide API Revenue Market Share by Region (2017-2022)
    Table 20. Global Oligonucleotide API Revenue by Region (2023-2028) & (US$ Million)
    Table 21. Global Oligonucleotide API Revenue Market Share by Region (2023-2028)
    Table 22. Global Oligonucleotide API Production Capacity by Manufacturers (2017-2022) & (Ton)
    Table 23. Global Oligonucleotide API Capacity Market Share by Manufacturers (2017-2022)
    Table 24. Global Oligonucleotide API Sales by Manufacturers (2017-2022) & (Ton)
    Table 25. Global Oligonucleotide API Sales Market Share by Manufacturers (2017-2022)
    Table 26. Global Oligonucleotide API Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 27. Global Oligonucleotide API Revenue Share by Manufacturers (2017-2022)
    Table 28. Oligonucleotide API Price by Manufacturers 2017-2022 (US$/Ton)
    Table 29. Global Oligonucleotide API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 30. Global Oligonucleotide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide API as of 2021)
    Table 31. Oligonucleotide API Manufacturing Base Distribution and Headquarters
    Table 32. Manufacturers Oligonucleotide API Product Offered
    Table 33. Date of Manufacturers Enter into Oligonucleotide API Market
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 36. Global Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 37. Global Oligonucleotide API Sales Share by Type (2017-2022)
    Table 38. Global Oligonucleotide API Sales Share by Type (2023-2028)
    Table 39. Global Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 40. Global Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 41. Global Oligonucleotide API Revenue Share by Type (2017-2022)
    Table 42. Global Oligonucleotide API Revenue Share by Type (2023-2028)
    Table 43. Oligonucleotide API Price by Type (2017-2022) & (US$/Ton)
    Table 44. Global Oligonucleotide API Price Forecast by Type (2023-2028) & (US$/Ton)
    Table 45. Global Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 46. Global Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 47. Global Oligonucleotide API Sales Share by Application (2017-2022)
    Table 48. Global Oligonucleotide API Sales Share by Application (2023-2028)
    Table 49. Global Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 50. Global Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 51. Global Oligonucleotide API Revenue Share by Application (2017-2022)
    Table 52. Global Oligonucleotide API Revenue Share by Application (2023-2028)
    Table 53. Oligonucleotide API Price by Application (2017-2022) & (US$/Ton)
    Table 54. Global Oligonucleotide API Price Forecast by Application (2023-2028) & (US$/Ton)
    Table 55. North America Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 56. North America Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 57. North America Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 58. North America Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 59. North America Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 60. North America Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 61. North America Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 62. North America Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 63. North America Oligonucleotide API Sales by Country (2017-2022) & (Ton)
    Table 64. North America Oligonucleotide API Sales by Country (2023-2028) & (Ton)
    Table 65. North America Oligonucleotide API Revenue by Country (2017-2022) & (US$ Million)
    Table 66. North America Oligonucleotide API Revenue by Country (2023-2028) & (US$ Million)
    Table 67. Europe Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 68. Europe Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 69. Europe Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 70. Europe Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 71. Europe Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 72. Europe Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 73. Europe Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 74. Europe Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 75. Europe Oligonucleotide API Sales by Country (2017-2022) & (Ton)
    Table 76. Europe Oligonucleotide API Sales by Country (2023-2028) & (Ton)
    Table 77. Europe Oligonucleotide API Revenue by Country (2017-2022) & (US$ Million)
    Table 78. Europe Oligonucleotide API Revenue by Country (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 80. Asia Pacific Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 81. Asia Pacific Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 83. Asia Pacific Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 84. Asia Pacific Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 85. Asia Pacific Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 86. Asia Pacific Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 87. Asia Pacific Oligonucleotide API Sales by Region (2017-2022) & (Ton)
    Table 88. Asia Pacific Oligonucleotide API Sales by Region (2023-2028) & (Ton)
    Table 89. Asia Pacific Oligonucleotide API Revenue by Region (2017-2022) & (US$ Million)
    Table 90. Asia Pacific Oligonucleotide API Revenue by Region (2023-2028) & (US$ Million)
    Table 91. Latin America Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 92. Latin America Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 93. Latin America Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 94. Latin America Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 95. Latin America Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 96. Latin America Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 97. Latin America Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 98. Latin America Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 99. Latin America Oligonucleotide API Sales by Country (2017-2022) & (Ton)
    Table 100. Latin America Oligonucleotide API Sales by Country (2023-2028) & (Ton)
    Table 101. Latin America Oligonucleotide API Revenue by Country (2017-2022) & (US$ Million)
    Table 102. Latin America Oligonucleotide API Revenue by Country (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Oligonucleotide API Sales by Type (2017-2022) & (Ton)
    Table 104. Middle East and Africa Oligonucleotide API Sales by Type (2023-2028) & (Ton)
    Table 105. Middle East and Africa Oligonucleotide API Revenue by Type (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Oligonucleotide API Revenue by Type (2023-2028) & (US$ Million)
    Table 107. Middle East and Africa Oligonucleotide API Sales by Application (2017-2022) & (Ton)
    Table 108. Middle East and Africa Oligonucleotide API Sales by Application (2023-2028) & (Ton)
    Table 109. Middle East and Africa Oligonucleotide API Revenue by Application (2017-2022) & (US$ Million)
    Table 110. Middle East and Africa Oligonucleotide API Revenue by Application (2023-2028) & (US$ Million)
    Table 111. Middle East and Africa Oligonucleotide API Sales by Country (2017-2022) & (Ton)
    Table 112. Middle East and Africa Oligonucleotide API Sales by Country (2023-2028) & (Ton)
    Table 113. Middle East and Africa Oligonucleotide API Revenue by Country (2017-2022) & (US$ Million)
    Table 114. Middle East and Africa Oligonucleotide API Revenue by Country (2023-2028) & (US$ Million)
    Table 115. Jazz Pharmaceuticals Corporation Information
    Table 116. Jazz Pharmaceuticals Description and Major Businesses
    Table 117. Jazz Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 118. Jazz Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Jazz Pharmaceuticals Recent Development
    Table 120. Sarepta Therapeutics Corporation Information
    Table 121. Sarepta Therapeutics Description and Major Businesses
    Table 122. Sarepta Therapeutics Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 123. Sarepta Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sarepta Therapeutics Recent Development
    Table 125. Biogen Corporation Information
    Table 126. Biogen Description and Major Businesses
    Table 127. Biogen Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 128. Biogen Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Biogen Recent Development
    Table 130. Dynavax Technologies Corporation Information
    Table 131. Dynavax Technologies Description and Major Businesses
    Table 132. Dynavax Technologies Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 133. Dynavax Technologies Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Dynavax Technologies Recent Development
    Table 135. Akcea Therapeutics Corporation Information
    Table 136. Akcea Therapeutics Description and Major Businesses
    Table 137. Akcea Therapeutics Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 138. Akcea Therapeutics Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Akcea Therapeutics Recent Development
    Table 140. Alnylam Pharmaceuticals Corporation Information
    Table 141. Alnylam Pharmaceuticals Description and Major Businesses
    Table 142. Alnylam Pharmaceuticals Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 143. Alnylam Pharmaceuticals Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Alnylam Pharmaceuticals Recent Development
    Table 145. Nitto Denko (Avecia) Corporation Information
    Table 146. Nitto Denko (Avecia) Description and Major Businesses
    Table 147. Nitto Denko (Avecia) Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 148. Nitto Denko (Avecia) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Nitto Denko (Avecia) Recent Development
    Table 150. Ajinomoto (GeneDesign) Corporation Information
    Table 151. Ajinomoto (GeneDesign) Description and Major Businesses
    Table 152. Ajinomoto (GeneDesign) Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 153. Ajinomoto (GeneDesign) Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Ajinomoto (GeneDesign) Recent Development
    Table 155. RiboBio Corporation Information
    Table 156. RiboBio Description and Major Businesses
    Table 157. RiboBio Oligonucleotide API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 158. RiboBio Oligonucleotide API Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. RiboBio Recent Development
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Oligonucleotide API Distributors List
    Table 163. Oligonucleotide API Customers List
    Table 164. Oligonucleotide API Market Trends
    Table 165. Oligonucleotide API Market Drivers
    Table 166. Oligonucleotide API Market Challenges
    Table 167. Oligonucleotide API Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oligonucleotide API Product Picture
    Figure 2. Global Oligonucleotide API Market Share by Type in 2021 & 2028
    Figure 3. Antisense Oligonucleotides API Product Picture
    Figure 4. Small Interfering RNA (siRNA) API Product Picture
    Figure 5. MiRNA API Product Picture
    Figure 6. CpG Oligonucleotides API Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Oligonucleotide API Market Share by Application in 2021 & 2028
    Figure 9. Contract Manufacturing Organizations (CMOs)
    Figure 10. Pharmaceutical Companies
    Figure 11. Oligonucleotide API Report Years Considered
    Figure 12. Global Oligonucleotide API Capacity, Production and Utilization (2017-2028) & (Ton)
    Figure 13. Global Oligonucleotide API Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Oligonucleotide API Production Market Share by Region (2017-2022)
    Figure 15. Global Oligonucleotide API Production Market Share by Region (2023-2028)
    Figure 16. Oligonucleotide API Production Growth Rate in North America (2017-2028) & (Ton)
    Figure 17. Oligonucleotide API Production Growth Rate in Europe (2017-2028) & (Ton)
    Figure 18. Oligonucleotide API Production Growth Rate in China (2017-2028) & (Ton)
    Figure 19. Oligonucleotide API Production Growth Rate in Japan (2017-2028) & (Ton)
    Figure 20. Global Oligonucleotide API Sales 2017-2028 (Ton)
    Figure 21. Global Oligonucleotide API Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 22. Global Oligonucleotide API Revenue 2017-2028 (US$ Million)
    Figure 23. Global Oligonucleotide API Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 24. Global Oligonucleotide API Sales Market Share by Region (2017-2022)
    Figure 25. Global Oligonucleotide API Sales Market Share by Region (2023-2028)
    Figure 26. North America Oligonucleotide API Sales YoY (2017-2028) & (Ton)
    Figure 27. North America Oligonucleotide API Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Oligonucleotide API Sales YoY (2017-2028) & (Ton)
    Figure 29. Europe Oligonucleotide API Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Oligonucleotide API Sales YoY (2017-2028) & (Ton)
    Figure 31. Asia-Pacific Oligonucleotide API Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. Latin America Oligonucleotide API Sales YoY (2017-2028) & (Ton)
    Figure 33. Latin America Oligonucleotide API Revenue YoY (2017-2028) & (US$ Million)
    Figure 34. Middle East & Africa Oligonucleotide API Sales YoY (2017-2028) & (Ton)
    Figure 35. Middle East & Africa Oligonucleotide API Revenue YoY (2017-2028) & (US$ Million)
    Figure 36. The Oligonucleotide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 37. The Top 5 and 10 Largest Manufacturers of Oligonucleotide API in the World: Market Share by Oligonucleotide API Revenue in 2021
    Figure 38. Oligonucleotide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 39. Global Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 40. Global Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 41. Global Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 42. Global Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 43. North America Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 44. North America Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 45. North America Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 46. North America Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 47. North America Oligonucleotide API Sales Share by Country (2017-2028)
    Figure 48. North America Oligonucleotide API Revenue Share by Country (2017-2028)
    Figure 49. U.S. Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 50. Canada Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 51. Europe Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 52. Europe Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 53. Europe Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 54. Europe Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 55. Europe Oligonucleotide API Sales Share by Country (2017-2028)
    Figure 56. Europe Oligonucleotide API Revenue Share by Country (2017-2028)
    Figure 57. Germany Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 58. France Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 59. U.K. Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 60. Italy Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 61. Russia Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 62. Asia Pacific Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 63. Asia Pacific Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 64. Asia Pacific Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 65. Asia Pacific Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 66. Asia Pacific Oligonucleotide API Sales Share by Region (2017-2028)
    Figure 67. Asia Pacific Oligonucleotide API Revenue Share by Region (2017-2028)
    Figure 68. China Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 69. Japan Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 70. South Korea Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 71. India Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 72. Australia Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 73. Taiwan Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 74. Indonesia Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 75. Thailand Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 76. Malaysia Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 77. Philippines Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 78. Latin America Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 79. Latin America Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 80. Latin America Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 81. Latin America Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 82. Latin America Oligonucleotide API Sales Share by Country (2017-2028)
    Figure 83. Latin America Oligonucleotide API Revenue Share by Country (2017-2028)
    Figure 84. Mexico Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 85. Brazil Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 86. Argentina Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 87. Middle East and Africa Oligonucleotide API Sales Market Share by Type (2017-2028)
    Figure 88. Middle East and Africa Oligonucleotide API Revenue Market Share by Type (2017-2028)
    Figure 89. Middle East and Africa Oligonucleotide API Sales Market Share by Application (2017-2028)
    Figure 90. Middle East and Africa Oligonucleotide API Revenue Market Share by Application (2017-2028)
    Figure 91. Middle East and Africa Oligonucleotide API Sales Share by Country (2017-2028)
    Figure 92. Middle East and Africa Oligonucleotide API Revenue Share by Country (2017-2028)
    Figure 93. Turkey Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 94. Saudi Arabia Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 95. UAE Oligonucleotide API Revenue (2017-2028) & (US$ Million)
    Figure 96. Oligonucleotide API Value Chain
    Figure 97. Oligonucleotide API Production Process
    Figure 98. Channels of Distribution
    Figure 99. Distributors Profiles
    Figure 100. Bottom-up and Top-down Approaches for This Report
    Figure 101. Data Triangulation
    Figure 102. Key Executives Interviewed